123 related articles for article (PubMed ID: 8548599)
1. Expression of cathepsin D in human astrocytic neoplasias.
Warich M; von Bossanyi P; Dietzmann K
Gen Diagn Pathol; 1995 Oct; 141(2):93-6. PubMed ID: 8548599
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
4. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
[TBL] [Abstract][Full Text] [Related]
5. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.
Vandeputte DA; Troost D; Leenstra S; Ijlst-Keizers H; Ramkema M; Bosch DA; Baas F; Das NK; Aronica E
Glia; 2002 Jun; 38(4):329-38. PubMed ID: 12007145
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
Dietzmann K; von Bossanyi P
Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981
[TBL] [Abstract][Full Text] [Related]
7. [Nitric oxide synthase in neuroepithelial brain tumors].
Sosunov AA; Chairkin IN; Odyvanova LR; Guski G; Tservos-Navarro DZh
Arkh Patol; 1997; 59(6):61-5. PubMed ID: 9483223
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological study on malignant glioma--with special reference to GFAP].
Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
[TBL] [Abstract][Full Text] [Related]
9. Patterns of expression of TSC-22 protein in astrocytic gliomas.
Shostak KO; Dmitrenko VV; Vudmaska MI; Naidenov VG; Beletskii AV; Malisheva TA; Semenova VM; Zozulya YP; Demotes-Mainard J; Kavsan VM
Exp Oncol; 2005 Dec; 27(4):314-8. PubMed ID: 16404353
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.
Broholm H; Laursen H
APMIS; 2004; 112(4-5):257-63. PubMed ID: 15233640
[TBL] [Abstract][Full Text] [Related]
11. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.
Mennel HD; Lell B
Clin Neuropathol; 2005; 24(1):13-8. PubMed ID: 15696779
[TBL] [Abstract][Full Text] [Related]
13. CD44 expression in astrocytic tumors.
Ylagan LR; Quinn B
Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
Yamamoto M; Ikeda K; Ohshima K; Tsugu H; Kimura H; Tomonaga M
Cancer Res; 1997 Jul; 57(13):2799-805. PubMed ID: 9205092
[TBL] [Abstract][Full Text] [Related]
15. Expression of the DNA repair enzyme, N-methylpurine-DNA glycosylase (MPG) in astrocytic tumors.
Kim NK; Ahn JY; Song J; Kim JK; Han JH; An HJ; Chung HM; Joo JY; Choi JU; Lee KS; Roy R; Oh D
Anticancer Res; 2003; 23(2B):1417-23. PubMed ID: 12820404
[TBL] [Abstract][Full Text] [Related]
16. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system.
Bresalier RS; Yan PS; Byrd JC; Lotan R; Raz A
Cancer; 1997 Aug; 80(4):776-87. PubMed ID: 9264362
[TBL] [Abstract][Full Text] [Related]
17. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
18. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
19. Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma.
Reeves SA; Chavez-Kappel C; Davis R; Rosenblum M; Israel MA
Cancer Res; 1992 Dec; 52(24):6871-6. PubMed ID: 1333884
[TBL] [Abstract][Full Text] [Related]
20. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
Mai J; Sameni M; Mikkelsen T; Sloane BF
Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
